Cancer
Our program is prevention-led: we uncover modifiable drivers of cancer and translate them into earlier detection, risk prediction, and better treatment outcomes.
Combining biosensors, with synthetic, digital and space biology, we co-design equitable solutions with metropolitan, regional and remote communities, including First Nations peoples.
We investigate lifestyle, environmental and biological factors that initiate or accelerate cancer, identifying targets for prevention. We build and validate low-cost, point-of-care biosensors and synthetic/digital/space biology platforms to predict risk, detect cancer early, and monitor treatment response and relapse. These technologies are integrated with precision therapies and molecular studies to improve outcomes while ensuring accessibility and cultural safety through partnerships with rural, regional and First Nations communities. Our pipeline spans discovery to implementation, moving innovations from bench to bedside and into community settings.